The Connectivity Map: a new tool for biomedical research
The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
The ultimate objective of biomedical research is to connect human diseases with the genes that underlie them and drugs that treat them. But this remains a daunting task, and even the most inspired researchers still have to resort to laborious screens of genetic or chemical libraries. What if at least some parts of this screening process could be systematized and centralized? And hits found and hypotheses generated with something resembling an internet search engine? These are the questions the Connectivity Map project set out to answer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, they do not support complex molecular readouts such as transcriptome profiling, which is one of the most comprehensive and informative measures of cellular response 5 .”
From Pooled CRISPR screening with single-cell transcriptome readout. (2017) · cites this paper as [5]
In the citing paper
“This tool allowed researchers to investigate genome-wide effects of GHK and establish that GHK-Cu is able to up- and down-regulate a significant number of human genes.”
From Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data (2018) · cites this paper as [3]
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,782
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
Self-citationDruker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J. M., Lydon, N. B., Kantarjian, H., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,243 · cited 1×
“) to rationality (chronic myeloid leukaemia–BCR-ABL–imatini”
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform
Rhodes, D. R., Yu, J., Shanker, K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T., Pander, A., & Chinnaiyan, A. M. (2004) · Neoplasia · doi:10.1016/s1476-5586(04)80047-2 · Cited by 3,612
A gene atlas of the mouse and human protein-encoding transcriptomes
Su, A. I., Wiltshire, T., Batalov, S., Lapp, H., Ching, K. A., Block, D., Zhang, J., Soden, R., Hayakawa, M., Kreiman, G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400782101 · Cited by 3,475
Cited by
Items 401–500 of 984
Kuo, Y.-L., Chen, C., Chuang, T., Hua, W.-K., Lin, W., Hsu, W., Chang, P. M., Hsu, S., Huang, T., Kao, C.-Y., et al. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/917345 · Cited by 22
“A gene pattern-matching tool, Connectivity Map (CMap), was utilized to identify small molecules that have a strong association with PG2 by searching for highly similar gene expression patterns (Figure 1).”
BackgroundMethodInfluentialFowler, K. D., Funt, J. M., Artyomov, M. N., Zeskind, B. J., Kolitz, S. E., & Towfic, F. (2015) · Scientific Reports · doi:10.1038/srep14324 · Cited by 22
Li, Y., Thomas, D., Deutzmann, A., Majeti, R., Felsher, D. W., & Dill, D. L. (2019) · Scientific Reports · doi:10.1038/s41598-019-53290-3 · Cited by 20
Bioinformatic Analyses of the Ferroptosis-Related lncRNAs Signature for Ovarian Cancer
Zheng, J., Guo, J., Wang, Y., Zheng, Y., Zhang, K., & Tong, J. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.735871 · Cited by 19
“Candidate small molecular drugs and mechanisms of action were predicted via uploadingDEGs to CMAP database (Lamb et al., 2006; Lamb, 2007).”
MethodFrom NPC Therapeutic Target Identification to Potential Treatment Strategy
Lan, M., Chen, C., Lin, K., Lee, S., Yang, W.-L. R., Hsu, C.-N., Wu, J., Ho, C., Lin, J., & Huang, C. F. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0966 · Cited by 19
Lauria, M. (2013) · Systems Biomedicine · doi:10.4161/sysb.25982 · Cited by 20
Soleilhac, E., Nadon, R., & Lafanéchère, L. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460440903544456 · Cited by 23
“This initiative facilitates discovery of connections among small molecules sharing a mechanism of action and of disease [72-74] .”
BackgroundPathway-based Bayesian inference of drug–disease interactions
Pratanwanich, P. N., & Lió, P. (2014) · Molecular BioSystems · doi:10.1039/c4mb00014e · Cited by 18
Brown, J. B., Niijima, S., & Okuno, Y. (2013) · Molecular Informatics · doi:10.1002/minf.201300101 · Cited by 18
van Berlo, R. J. P., Winterbach, W., de Groot, M. J. L., Bender, A., Verheijen, P. J. T., Reinders, M. J. T., & de Ridder, D. (2013) · International Journal of Bioinformatics Research and Applications · doi:10.1504/ijbra.2013.054688 · Cited by 18
“Then we demonstrate the use of the MCS metric in an application predicting the transcriptional response of breast cancer cell lines to different drug-like compounds at a scale that was, until now, infeasible due to the computational complexity[19,18].”
MethodExpanding the Immunology Toolbox: Embracing Public-Data Reuse and Crowdsourcing
Sparks, R., Lau, W. W., & Tsang, J. S. (2016) · Immunity · doi:10.1016/j.immuni.2016.12.008 · Cited by 19
Personalized Network Modeling of the Pan-Cancer Patient and Cell Line Interactome
Bhattacharyya, R., Ha, M. J., Liu, Q., Akbani, R., Liang, H., & Baladandayuthapani, V. (2020) · JCO Clinical Cancer Informatics · doi:10.1200/cci.19.00140 · Cited by 18
Yao, M., Gao, C., Zhang, C., Di, X., Liang, W., Sun, W., Wang, Q., & Zheng, Z. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.583629 · Cited by 21
“The CMap database is a database of drug-related gene expression profiles, and it consists of a large amount of genome-wide transcriptional expression data of cell lines treated with small molecular compounds to reveal the correlation among genes, diseases, and drugs (Lamb, 2007).”
BackgroundA Novel Immune-Related ceRNA Network and Relative Potential Therapeutic Drug Prediction in ccRCC
Li, W., Meng, X., Yuan, H., Xiao, W., & Zhang, X. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2021.755706 · Cited by 18
“Connectivity Map (Cmap) (Lamb, 2007) was a common small-molecular drug-prediction database, so we predicted potential therapeutic chemicals for ccRCC through three genes (NR3C2, VAV3, and HAMP) associated with miR-186-5p.”
BackgroundPunekar, M., Kasabe, B., Patil, P., Kakade, M. B., Parashar, D., Alagarasu, K., & Cherian, S. (2022) · Viruses · doi:10.3390/v14102150 · Cited by 22
“io site helps in identifying perturbens that give rise to similar (or opposing) gene signatures [14].”
BackgroundHe, J., Yan, H., Cai, H., Li, X., Guan, Q., Zheng, W., Chen, R., Liu, H., Song, K., Guo, Z., et al. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1302-9 · Cited by 18
“As an important public data source, the Connectivity Map (CMAP) [3, 6] has been widely applied to study drug repositioning [2, 7, 8] and drug action mechanisms [9, 10].”
BackgroundMethodXiao, S., Zhu, X.-C., Deng, H., Zhou, W., Yang, W.-Y., Yuan, L.-K., Zhang, J., Tian, S., Lu, X., Zhang, L., et al. (2018) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2018.02.060 · Cited by 18
Systems Genetics for Mechanistic Discovery in Heart Diseases
Rau, C. D., Lusis, A. J., & Wang, Y. (2020) · Circulation Research · doi:10.1161/circresaha.119.315863 · Cited by 20
Liu, J., Liao, X., Zhu, X., Lv, P., & Li, R. (2020) · Cancer Medicine · doi:10.1002/cam4.3361 · Cited by 19
Kwon, E., Mashelkar, K. K., Seo, J., Shin, Y.-Z., Sung, K., Jang, S. C., Cheon, S. W., Lee, H., Lee, H. W., Kim, G., et al. (2023) · ACS Central Science · doi:10.1021/acscentsci.3c00332 · Cited by 18
Chen, Y., Zhou, Y., Xue, F., Wu, Z., Yang, Y., Rao, X., Zhou, R., Meng, R., Dong, X., Xu, S., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06484-1 · Cited by 18
Exploring the complexity of pathway–drug relationships using latent Dirichlet allocation
Pratanwanich, P. N., & Lió, P. (2014) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2014.08.019 · Cited by 17
Identification of gene markers associated with metastasis in clear cell renal cell carcinoma
Yang, H., Huo, P., Hu, G., Wei, B., Kong, D., & Li, H. (2017) · Oncology Letters · doi:10.3892/ol.2017.6084 · Cited by 17
“The Connectivity Map (cmap; http://www.broadinstitute.org/CMAP/) database may be used to investigate connections among small drug molecules, genes and diseases (22,23).”
TNK2 as a key drug target for the treatment of metastatic colorectal cancer
Qi, L., & Ding, Y. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.07.124 · Cited by 17
Towards the routine use of in silico screenings for drug discovery using metabolic modelling
Bintener, T., Pacheco, M. P., & Sauter, T. (2020) · Biochemical Society Transactions · doi:10.1042/bst20190867 · Cited by 18
Identification of proteasome inhibitors using analysis of gene expression profiles
Mofers, A., Selvaraju, K., Gubat, J., D’Arcy, P., & Linder, S. T. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173709 · Cited by 17
“The association between alterations in gene expression patterns induced by gene deletion or by exposure to small molecules is referred to as “ connectivity ” (Lamb, 2007).”
BackgroundGemcitabine-Resistant Biomarkers in Bladder Cancer are Associated with Tumor-Immune Microenvironment
Song, Y., Du, Y., Qin, C., Liang, H., Yang, W., Lin, J., Ding, M., Han, J., & Xu, T. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.809620 · Cited by 22
“org/cmap) (Lamb et al., 2006; Lamb, 2007) was utilized to explore the potential drugs with antagonism or synergism to GEM-resistance.”
BackgroundMethodDownstream Gene Activation of the Receptor ALX by the Agonist Annexin A1
Renshaw, D. W., Montero‐Melendez, T., Dalli, J., Kamal, A. M., Brancaleone, V., D’Acquisto, F., Cirino, G., & Perretti, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012771 · Cited by 20
“This map represents a tool for the large-scale discovery of connections among small molecules, genes and diseases [30,31].”
Nevado‐Holgado, A. J., & Lovestone, S. (2016) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2016.10.003 · Cited by 19
“The CMap study is a publically accessible resource of gene expression derived from immortalised cell lines (MCF7, PC3 and HL60 cells), exposed to a large range of compounds at different concentrations [35,36].”
BackgroundHuang, T., Wu, S., Huang, Y.-J., Wei, P., Wu, A. T. H., & Chao, T.-Y. (2017) · Europe PMC (PubMed Central) · Cited by 19
Mori, G., Orena, B. S., Franch, C., Mitchenall, L. A., Godbole, A. A., Rodrigues, L., Aguilar-Pérez, C., Zemanová, J., Huszár, S., Forbak, M., et al. (2018) · Tuberculosis · doi:10.1016/j.tube.2018.08.004 · Cited by 18
Foekens, J. A., Wang, Y., Martens, J. W. M., Berns, E. M. J. J., & Klijn, J. G. M. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.03.003 · Cited by 17
Gu, Z., Ye, F., Luo, H., Li, X., Gong, Y., Mao, S., Jia, X., Han, X., Han, B.-Y., Fu, Y., et al. (2025) · Journal of Biomedical Science · doi:10.1186/s12929-025-01129-7 · Cited by 20
Nicolau, C. A., Prorock, A. J., Bao, Y., Neves‐Ferreira, A. G. C., Valente, R. H., & Fox, J. W. (2018) · Toxins · doi:10.3390/toxins10020069 · Cited by 18
“MCF7 cells were used in this work since most of the C-map database information relies on assays using this cell type, due to its extensive molecular characterization and ubiquitous use as a reference cell line [32].”
BackgroundMethodRepurposing of omeprazole for oligodendrocyte differentiation and remyelination
Zhu, K., Sun, J., Zheng, K., Zou, Z., Wu, X., Wang, Y.-Q., Wu, G.-C., Harris, R. A., & Wang, J. (2018) · Brain Research · doi:10.1016/j.brainres.2018.12.037 · Cited by 16
Bastiani, M. A. D., & Klamt, F. (2019) · Cancer Medicine · doi:10.1002/cam4.2493 · Cited by 17
Computational Methods for the Integrative Analysis of Genomics and Pharmacological Data
Caroli, J., Dori, M., & Bicciato, S. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00185 · Cited by 17
LINCS dataset-based repositioning of rosiglitazone as a potential anti-human adenovirus drug
Wang, X., He, S., Zhou, Z., Bo, X., Qi, D., Fu, X., Wang, Z., Yang, J., & Wang, S. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104789 · Cited by 16
Functional Gene Module–Based Identification of Phillyrin as an Anticardiac Fibrosis Agent
Wang, L., Zhang, W., Lu, Z., Wang, B., Li, Y., Yang, J., Li, P., & Zhao, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01077 · Cited by 16
“The gene expression profile is a common vocabulary used to translate diseases and drug action into the same language (Lamb, 2007).”
BackgroundYu, W. Y.-H., Hill, S. T., Chan, E. R., Pink, J. J., Cooper, K. D., Leachman, S. A., Lund, A. W., Kulkarni, R. P., & Bordeaux, J. S. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.12.015 · Cited by 16
Sánchez‐Hidalgo, M., Pascual, J., de la Cruz, M., Martı́n, J., Kath, G. S., SIGMUND, J. M., Masurekar, P. S., Vicente, F., Genilloud, O., & Bills, G. F. (2012) · Antonie van Leeuwenhoek · doi:10.1007/s10482-012-9746-7 · Cited by 16
“2006; Davies and Ryan 2011), or they can be more broadly defined as ‘‘perturbagens’’ if they modulate cell signaling pathways and cell growth and development in model organisms, including humans (Lamb 2007).”
BackgroundA cytokine protein-protein interaction network for identifying key molecules in rheumatoid arthritis
Panga, V., & Raghunathan, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199530 · Cited by 18
KalantarMotamedi, Y., Ejeian, F., Sabouhi, F., Bahmani, L., Nejati, A. S., Bhagwat, A. M., Ahadi, A. M., Tafreshi, A. P., Nasr‐Esfahani, M. H., & Bender, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-91629-x · Cited by 17
Wang, K., Zhang, M., Wang, J., Sun, P., Luo, J., Jin, H., Li, R., Pan, C., & Lu, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.737152 · Cited by 22
“edu/cmap) is a drug discovery database (27, 28).”
BackgroundLiberante, F. G., Pouryahya, T., McMullin, M., Zhang, S., & Mills, K. (2015) · Oncotarget · doi:10.18632/oncotarget.6773 · Cited by 16
“, it is based on the empirical observation that a transcriptome reflects the state of a cell in a given condition [7, 8].”
BackgroundRepurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer
Bibby, B. A. S., Thiruthaneeswaran, N., Yang, L., Pereira, R. R., Moré, E., McArt, D. G., O’Reilly, P. G., Bristow, R. G., Williams, K. J., Choudhury, A., et al. (2021) · BMC Urology · doi:10.1186/s12894-021-00856-x · Cited by 15
Yan, Q., Zhang, X., Xie, Y., Yang, J., Liu, C., Zhang, M., Zheng, W., Lin, X., Huang, H.-T., Liu, X., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-05837-y · Cited by 21
“The pharmacogenetic association data were derived from Connectivity Map (CAMP, https://portals.broadinstitute.org/cmap/) 25 , Comparative Tox-icogenomics Database (CTD; http://CTD.mdibl.org) 26 and Drugbank (https://go.drugbank.com/) 27 .”
Mashima, T. (2017) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.16-00229-1 · Cited by 15
Andersen, M. E., Pendse, S. N., Black, M. B., & McMullen, P. D. (2018) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2018.05.003 · Cited by 15
Li, P., Chen, J., Zhang, W., Li, H., Wang, W., & Chen, J. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.12.016 · Cited by 16
“The differential expression between the classes can be used as a marker of the activity of a given drug or phenotype to find the connections among drugs and phenotypes using their transcriptional responses [12,22,23].”
BackgroundRooney, J. P., Ryan, N., Liu, J., Houtman, R., van Beuningen, R., Hsieh, J., Chang, G., Chen, S., & Corton, J. C. (2021) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00243 · Cited by 15
Identification of Tumor Microenvironment-Related Prognostic Genes in Sarcoma
Dai, D., Xie, L., Shui, Y., Li, J., & Wei, Q. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.620705 · Cited by 15
“This enables accurate drug identification for certain disease phenotypes (Lamb, 2007; Musa et al., 2018).”
BackgroundDrug repositioning by merging active subnetworks validated in cancer and COVID-19
Lucchetta, M., & Pellegrini, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-99399-2 · Cited by 16
Shi, H., Han, L., Zhao, J., Wang, R. C., Xu, M., Shi, J., & Dong, Z. (2021) · Cancer Medicine · doi:10.1002/cam4.4377 · Cited by 15
Yongsheng, Y., Sun, X., Chen, F., & Liu, M. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.812674 · Cited by 19
“By comparing the queried and existing gene signatures, links can be found between gene knockout/ overexpression or small molecules with similar or opposite effects (Lamb, 2007).”
BackgroundIdentification of potential pathways and biomarkers linked to progression in ALS
Huber, R. G., Pandey, S., Chhangani, D., Rincón-Limas, D. E., Staff, N. P., & Yeo, C. J. J. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51697 · Cited by 15
Molineris, I., Ala, U., Provero, P., & Cunto, F. D. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-288 · Cited by 16
“The strongest initiative in this sense is the Connectivity Map (CMap), a collection of genome-wide transcriptional expression data from cultured human cells treated with bioactive small molecules that allows the discovery of functional connections between drugs, genes and diseases through the analysis of common gene-e…”
BackgroundMethodKalantarMotamedi, Y., Peymani, M., Baharvand, H., Nasr‐Esfahani, M. H., & Bender, A. (2016) · Cell Death Discovery · doi:10.1038/cddiscovery.2016.7 · Cited by 15
Bioinformatics Approaches to Predict Drug Responses from Genomic Sequencing
Madhukar, N. S., & Elemento, O. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7493-1_14 · Cited by 18
Anti-tumor activity of phenoxybenzamine and its inhibition of histone deacetylases
Inchiosa, M. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198514 · Cited by 15
HNCDB: An Integrated Gene and Drug Database for Head and Neck Cancer
Zhang, Q., Li, X., Su, X., Zhang, H., Wang, H., Yin, S., Pei, X., Yang, A., & Zuo, Z. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00371 · Cited by 15
Lu, L., Wen, Y., Yao, Y., Chen, F., Wang, G., Wu, F., Wu, J., Narayanan, P., Redell, M. S., Mo, Q., et al. (2018) · Theranostics · doi:10.7150/thno.22800 · Cited by 17
“Connectivity Map (C-map) (32, 33) was used to search”
MethodBusby, J., Murray, L., Mills, K., Zhang, S., Liberante, F. G., & Cardwell, C. R. (2017) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4345 · Cited by 15
“First, this could reflect the weaknesses of connectivity mapping, perhaps due to a reliance on cell cultures, and difficulty interpreting connectivity scores.(13) It may be that the doses prescribed in routine clinical practice are insufficiently large for the cancer causing or protective effects identified during the…”
BackgroundYen, C., Chen, L., Li, C., Chen, S., Chua, W., Lin, Y., Yen, C., Chen, Y., Yang, M., Chao, Y., et al. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4829 · Cited by 15
“All instances in the database were then ranked according to their connectivity scores; those at the top were most strongly associated with the query signature, and those at the bottom were most strongly anti-associated (22,23).”
BackgroundZhu, J., Wang, Y., Hu, Q., Yuan, R., & Ye, J. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104780 · Cited by 14
Learning to encode cellular responses to systematic perturbations with deep generative models
Xue, Y., Ding, M. Q., & Lu, X. (2020) · npj Systems Biology and Applications · doi:10.1038/s41540-020-00158-2 · Cited by 16
Villanueva, P. J., Gutiérrez, D. A., Contreras, L., Parra, K., Segura‐Cabrera, A., Varela-Ramírez, A., & Aguilera, R. J. (2021) · Clinical Cancer Drugs · doi:10.2174/2212697x08666210219101023 · Cited by 14
Ladumor, Y., Seong, B. K. A., Hallett, R. M., Valencia-Sama, I., Adderley, T., Wang, Y., Kee, L., Gont, A., Kaplan, D. R., & Irwin, M. S. (2022) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-0425 · Cited by 14
Integrating Constitutive Gene Expression and Chemoactivity: Mining the NCI60 Anticancer Screen
Covell, D. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044631 · Cited by 14
“While the importance of these diverse factors on compound efficacy continues to be actively pursued [9], the challenge of linking measures of on- and off-target gene expressions to small molecule screening chemoactivity continues to hold promise for identifying cellular pathways important to efficacy [10], clinical bi…”
BackgroundMethodImage-based drug screen identifies HDAC inhibitors as novel Golgi disruptors synergizing with JQ1
Gendarme, M., Baumann, J., Ignashkova, T. I., Lindemann, R. K., & Reiling, J. H. (2017) · Molecular Biology of the Cell · doi:10.1091/mbc.e17-03-0176 · Cited by 15
In Silico Databases and Tools for Drug Repurposing
Serçinoğlu, O., & Özbek, P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816125-8.00024-9 · Cited by 16
Wu, D., Pepowski, B., Takahashi, S., & Kron, S. J. (2019) · BMC Genomics · doi:10.1186/s12864-019-5653-x · Cited by 17
Chemical genomic analysis of GPR35 signaling
Hu, H., Deng, H., Ling, S., Sun, H., Kenakin, T., Liang, X., & Ye, F. (2017) · Integrative Biology · doi:10.1039/c7ib00005g · Cited by 14
Jun, H. Y., Kim, T., Choi, J. W., Lee, Y. H., Lee, K. K., & Yoon, K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178204 · Cited by 14
Li, B., Hu, J., & Xu, H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1455383 · Cited by 16
“It includes approximately 3000 small molecules with clear mechanisms of action (MOA), affected pathways, and target proteins, revealing relationships between diseases, genes and drugs (42, 43).”
Wang, L., Markus, H., Chen, D., Chen, S., Zhang, F., Gao, S., Khunsriraksakul, C., Chen, F., Olsen, N. J., Foulke, G., et al. (2025) · Cell Genomics · doi:10.1016/j.xgen.2025.100820 · Cited by 17
de Almeida, T. S., Arantes, M. R., Neto, J. J. L., de Souza, T. M., Pessoa, I. P., de Medeiros, J. L., Tabosa, P. M. S., Moreira, T. B., Farias, D. F., & Carvalho, A. F. U. (2020) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2020.1731035 · Cited by 13
“Comparative analysis of gene expression data The differentially expressed genes obtained in the present study were further analyzed using the Connectivity Map (CMAP) database (Lamb 2007; Lamb et al. 2006).”
MethodIdentifying Gene Signatures for Cancer Drug Repositioning Based on Sample Clustering
Wang, F., Ding, Y., Lei, X., Liao, B., & Wu, F. (2020) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2020.3019781 · Cited by 14
“Lamb et al. construct a Connectivity Map (CMap) database [9], [10].”
BackgroundFu, Y.-H., Tseng, C.-Y., Lu, J., Lu, W., Lan, P.-Q., Chen, C., Ou, D., & Lin, L. (2021) · Biomedicines · doi:10.3390/biomedicines9121869 · Cited by 15
“Furthermore, to explore the mechanism by which pyrvinium induces the inhibition of Molm13 cells, several chemicals affecting gene expression patterns in a similar manner as pyrvinium were screened using a connectivity map [63,64].”
MethodDavis, A. P., Murphy, C. G., Saraceni-Richards, C. A., Rosenstein, M. C., Wiegers, T. C., Hampton, T. H., & Mattingly, C. J. (2009) · Bioinformation · doi:10.6026/97320630004173 · Cited by 13
Recovering Drug-Induced Apoptosis Subnetwork from Connectivity Map Data
Yu, J., Putcha, P., & Silva, J. M. (2015) · BioMed Research International · doi:10.1155/2015/708563 · Cited by 15
“Recently, Todd Golub and his colleagues at the Broad Institute initialized the “Connectivity Map” (CMAP) project [1, 2] to make these disease-genedrug connections by utilizing microarray technology.”
BackgroundImputing gene expression to maximize platform compatibility
Zhou, W., Han, L., & Altman, R. B. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw664 · Cited by 13
“For instance, the Connectivity Map (Lamb, 2007; Lamb et al. , 2006), Genomics of Drug Sensitivity in Cancer (Yang et al. , 2013) and the Cancer Cell Line Encyclopedia (CCLE) (Barretina et al. , 2012) use the high-throughput version of the HG-U133A array for gene expression analysis, whereas The…”
BackgroundInfluentialGao, H., Ni, Y., Mo, X., Li, D., Teng, S., Huang, Q., Huang, S., Liu, G., Zhang, S., Tang, Y., et al. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.06.046 · Cited by 14
“The first step in this method involves the iden-tification of disease-associated gene expression signatures, and then, the identification of drug-induced changes in gene expression using various resources, such as Connectivity Map (CMap) [10], in order to screen candidate drugs [11].”
MethodPang, X., Zhao, Y., Wang, J., Wan, L., Xiang, Q., Zhang, Z., Wu, S., Liu, A., Du, G., & Cui, Y. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8265958 · Cited by 13
“CMAP (http:// www.connectivitymap.org/cmap/) [37] was used to collect the genome-wide transcriptional expression data from cultured human cells treated with bioactive small molecules and simple pattern-matching algorithms that together facilitate the discovery of functional connections between drugs, genes, and diseas…”
BackgroundInfluentialLin, H., Fang, H., Wang, J., Meng, Q., Dai, X., Wu, S. L. Y., Luo, J., Pu, D., Chen, L., Minick, D. J., et al. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.05.084 · Cited by 14
The tripeptide, GHK, induces programmed cell death in SH-SY5Y neuroblastoma cells
E. Matalka, L. (2012) · Journal of Biotechnology & Biomaterials · doi:10.4172/2155-952x.1000144 · Cited by 12
“The diversity of its actions in human is attributed to its ability to modulate the expression of a number of genes [4].”
BackgroundXu, Y., Li, J., Wang, J., & Deng, F. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05447-6 · Cited by 13
“To screen for small-molecule drugs against CCRGPI, we selected the 80 upregulated genes with the largest logFC and the 80 downregulated genes with the smallest logFC from DEGs for connectivity map (CMap) analysis (https:// clue. io/ query) [31].”
MethodPan‑cancer analysis on the role of KMT2C expression in tumor progression and immunotherapy
Cao, W., Xie, Y., Cai, L., Wang, M., Chen, Z., Wang, Z., Xv, J., Wang, Y., Li, R., Liu, X., et al. (2024) · Oncology Letters · doi:10.3892/ol.2024.14577 · Cited by 13
“The correlation between KMT2C expression and the sensitivity to small molecule inhibitors was investigated using the CMap (https://portals.broadinstitute.org/cmap/) and SPIED3 (92.205.225.222/HGNC‑SPIED3‑QF.py) web tools (27).”
InfluentialZhou, Y., Liu, Z., Cheng, G., Zhang, J., Zhao, J., Zhang, X., Liu, X., Li, B., Li, R., Shi, Z., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03111-x · Cited by 14
“Then, we searched for potential compounds targeting RMRs expression in various cancer types by using connectivity map analysis (CMap) [38], which was employed to reveal functional links between small molecule compounds, genes, and disease states.”
MethodUnlocking the potential of signature-based drug repurposing for anticancer drug discovery
Biswal, S., & Mallick, B. (2024) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2024.110150 · Cited by 13
Lou, S., Tihagam, R. D., Wasko, U. N., Equbal, Z., Venkatesan, S., Braczyk, K., Przanowski, P., Koo, B. I., Saltani, I., Singh, A. T., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61092-7 · Cited by 13
“We note that several FDA-approved drugs, such as Tazemetostat 54 , Imatinib 55 , Metformin 56 , and Aspirin 57 , induce multifactorialchanges ingene expression and yet arewell tolerated in humans 58,59 .”
Thakkar, P. V., Kita, K., del Castillo, U., Galletti, G., Madhukar, N. S., Vila-Navarro, E., Barasoaín, I., Goodson, H. V., Sackett, D. L., Díaz, J. F., et al. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.09.023 · Cited by 12
Huang, R., Liao, X., & Li, Q. (2022) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2022112 · Cited by 12
Bu, H., Cao, T., Li, X., Guo, Y., Guo, J., Wang, Y., Sun, Y., & Wang, D. (2022) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-22-665 · Cited by 12
Cypryk, W., Czernek, L., Horodecka, K., Chrzanowski, J., Stańczak, M., Nurmi, K., Bilicka, M., Gadzinowski, M., Walczak‐Drzewiecka, A., Stensland, M., et al. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200444 · Cited by 12
Approaches for sRNA Analysis of Human RNA-Seq Data: Comparison, Benchmarking
Bezuglov, V., Stupnikov, A., Skakov, I., Shtratnikova, V., Pilsner, J. R., Suvorov, A., & Sergeyev, O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044195 · Cited by 12
“These include the Connectivity Map [72,73], GO terms [74] and KEGG [75] pathways analysis, hallmark signatures inference [76], and genome browser analysis [77].”
MethodA multiomic investigation of lung adenocarcinoma molecular subtypes
Liang, K., Luo, Y., Wang, M., Chiou, S., Chen, Y., & Hsu, H. (2023) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000001029 · Cited by 12
“18 This tool comprises a catalog of gene expression profiles generated by a high-throughput pipeline and denoted as L1000.”
MethodConnections in pharmacology: innovation serving translational medicine
Montero‐Melendez, T., & Perretti, M. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.11.022 · Cited by 14
Karovic, S., Shiuan, E. F., Zhang, S., Cao, H., & Maitland, M. (2016) · Clinical and Translational Science · doi:10.1111/cts.12408 · Cited by 12
Tejera, E., Carrera, I., Jimenes-Vargas, K., Armijos‐Jaramillo, V., Sánchez‐Rodríguez, A., Cruz‐Monteagudo, M., & Pérez‐Castillo, Y. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223276 · Cited by 12
“• Approaches based on gene expression such as the well-known CMAP and L1000CDS2 methodologies [7–9].”
Method
Metadata
- Authors
- Lamb, J.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Lamb, Justin
- Venue
- Nature Reviews Cancer
- Published
- 2007-01
- Volume
- 7
- Issue
- 1
- Pages
- 54-60
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2029980980
- Semantic Scholar
- d1610ee5045d33be16a9a72a514fea537ba46306
- Cited by
- 945
- References
- 66
- Citations by year
- 2026: 11 · 2025: 29 · 2024: 75 · 2023: 54 · 2022: 56 · 2021: 100 · 2020: 79 · 2019: 64 · 2018: 60 · 2017: 52 · 2016: 58 · 2015: 57 · 2014: 42 · 2013: 49 · 2012: 56
- FWCI
- 1.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Broad Institute
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Keywords
- Connectivity Map, gene-disease association, drug repurposing, gene expression profiling, cancer research, drug discovery
- MeSH terms
- Algorithms, Animals, Gene Expression Regulation, Humans, Information Services, Models, Biological, Models, Genetic, Neoplasms, Phenotype, Software, Information Storage and Retrieval, Genome, Computational Biology, Biomedical Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.